Meet the Expert: GLP-1 RA and CV Risk Reduction in T2DM

Introduction

Take This Event

Dr. Lakshmanan will shed light on the role of GLP-1 RAs in the treatment of T2DM with a special focus on cardiovascular impact. Live lecture followed by Q&A.

Objectives

By the end of the lecture the audience should be able to:
1. Understand the different GLP-1 RA CV trials and outcomes to be able select appropriate therapy for the right patient
2. Look beyond glycemic control when considering therapy for T2DM patients who have other disease related risks

See Registration Policies, Cancellations & Refunds